ETFMG Treatments Testing and Advancements ETF’s (GERM) Moving Averages Convergence Divergence (MACD) indicator is 0.21, suggesting ETFMG Treatments Testing and Advancements ETF is a Sell.
ETFMG Treatments Testing and Advancements ETF’s (GERM) 20-Day exponential moving average is 18.89, making it a Buy.
ETFMG Treatments Testing and Advancements ETF’s (GERM) 50-Day exponential moving average is 18.66, making it a Buy.